| Print
Iovance Biotherapeutics (IOVA)
Common SharesNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Address
999 Skyway Road
Suite 150
San Carlos
CA
USA
94070
Telephone
+1 650 260-7120
Forecast key dates
| Name | Key Date |
|---|---|
| Iovance Biotherapeutics Inc Second Quarter Earnings Conference Call for 2026 | 2026-08-07T16:30:00 |
| Iovance Biotherapeutics Inc Second Quarter Earnings Results for 2026 | 2026-08-07T00:00:00 |
| Iovance Biotherapeutics Inc Annual General Meeting for 2026 | 2026-06-10T11:00:00 |
| Iovance Biotherapeutics Inc First Quarter Earnings Conference Call for 2026 | 2026-05-08T16:30:00 |
| Iovance Biotherapeutics Inc First Quarter Earnings Results for 2026 | 2026-05-08T00:00:00 |
| Iovance Biotherapeutics Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-27T16:30:00 |
| Iovance Biotherapeutics Inc Fourth Quarter Earnings Results for 2025 | 2026-02-27T00:00:00 |
| Iovance Biotherapeutics Inc Annual Report for 2025 | 2026-02-27T00:00:00 |
| Iovance Biotherapeutics Inc Third Quarter Earnings Conference Call for 2025 | 2025-11-07T16:30:00 |
| Iovance Biotherapeutics Inc Third Quarter Earnings Results for 2025 | 2025-11-07T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.